Chemical formula: C₂₇H₃₀F₆N₂O₂ Molecular mass: 528.53 g/mol PubChem compound: 6918296
Dutasteride reduces circulating levels of dihydrotestosterone (DHT) by inhibiting both type 1 and type 2, 5α-reductase isoenzymes which are responsible for the conversion of testosterone to DHT.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| G04CB02 | Dutasteride | G Genito urinary system and sex hormones → G04 Urologicals → G04C Drugs used in benign prostatic hypertrophy → G04CB Testosterone-5-alpha reductase inhibitors |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| DUTASTERIDE Capsules | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Dutasteride is an active ingredient of these brands:
Austria (AT)
Croatia (HR)
Ecuador (EC)
Estonia (EE)Israel (IL)
Italy (IT)Lithuania (LT)Malta (MT)New Zealand (NZ)Nigeria (NG)
Poland (PL)
Romania (RO)Singapore (SG)
South Africa (ZA)Spain (ES)Tunisia (TN)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
